Real-time process/quality control for HPC processing

References

• Warkentin PI, Nick L, Shpall EJ. FAHCT accreditation: common deficiencies during on-site inspections. Cytotherapy 2000;2:213–20.
   Google Scholar
• Kvalheim G. EBMT and ISHAGE-Europe create a foundation for inspection and accreditation in Europe. Cytotherapy 1999;1:363–4.
   Web of Science ®Google Scholar
• Zahnd D, Leibundgut K, Zenhäusern R et al. Implementation ofthe JACIE standards for a haematopoietic progenitor cell transplantation programme: a cost analysis. Bone Marrow Trans-plant 2004; in press.
   Google Scholar
• JACIE Accreditation Manual. Accreditation manual for blood and marrow progenitor cell processing, collection and transplanta-tion. Joint accreditation committee of ISHAGE-Europe and EBMT. May 1999. www.ebmt.org
   Google Scholar
• Keever-Taylor CA. Process control: application to the cell processing laboratory. Cytotherapy 2000;2:63— 73.
   Google Scholar
• Siena S, Bregni M, Brando B et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for auto-logous transplantation in cancer patients. Blood 1991;77:400–9.
   PubMed Web of Science ®Google Scholar
• McNiece I, Kern B, Zilm K et al. Minimization of CD34± cellenumeration variability using the ProCOUNT standardized methodology. 7 Hematother 1998;7:499–504.
   PubMedGoogle Scholar
• Serke S, Johnsen HE. A European reference protocol for qualityassessment and clinical validation of autologous haematopoietic blood progenitor and stem cell grafts. Bone Marrow Transplant 2001;27:463— 70.
   Google Scholar
• Leibundgut K, von Rohr A, Briilhart K et al. The number of circulating CD34± blood cells predicts the colony-forming capacity of leukapheresis products in children. Bone Marrow Transplant 1995;15:25— 31.
   Google Scholar
• Johnsen HE, Lanza E Quality Assessment of Autologous Hematopoietic Blood Progenitor and Stem Cell Grafting. A Prospective Registration Study. EBMT subcommittee on quality assessment of haemato-poietic stem cell grafts. http//www.EBMT.com.
   Google Scholar
• Barnett D, Granger V, Kraan J et al. Reduction of intra- and interlaboratory variation in CD34± stem cell enumeration using stable test material, standard protocols and targeted training. CD34 Task Force of the European Working Group of Clinical Cell Analysis (EWGCCA). Br y Haemat 2000;108:784–9.
   Google Scholar
• Rowley SD, Loken M, Radich J et al. Isolation of CD34± cellsfrom blood stem cell components using the Baxter Isolex system. Bone Marrow Transplant 1998;21:1253–62.
   PubMed Web of Science ®Google Scholar
• Cancelas JA, Querol S, Canals C et al. Peripheral blood CD34±cell immunomagnetic selection in breast cancer patients: effect on hematopoietic progenitor content and hematologic recovery after high-dose chemotherapy and autotransplantation. Transfu-sion 1998;38:1063–70.
   Google Scholar
• Martin-Henao GA, Picon M, Amill B et al. Isolation of CD34±progenitor cells from peripheral blood by use of an automated immunomagnetic selection system: factors affecting the results. Transfusion 2000;40:35–43.
   PubMed Web of Science ®Google Scholar
• Martin-Henao GA, Picon M, Rueda F et al. Combined isolationof CD34± progenitor cells and reduction of B cells from peripheral blood by use of immunomagnetic methods. Transfifr sion 2002;42:912 — 20.
   Google Scholar
• Espinosa MT, Fox R, Creger RJ, Lazarus HM. Microbiologic contamination of peripheral blood progenitor cells collected for hematopoietic cell transplantation. Transfusion 1996;36:789–93.
   PubMed Web of Science ®Google Scholar
• Attarian H, Bensinger WI, Buckner CD et al. Microbial contamination of peripheral blood stem cell collections. Bone Marrow Transplant 1996;17:699 — 702.
   Google Scholar
• Timeus F', Crescenzio N, Saracco P et al. Recovery of cord bloodhematopoietic progenitors after successive freezing and thawing procedures. Haematologica 2003;88:74— 9.
   Google Scholar
• Gratwohl A, Baldomero H, Horisberger B et al. Current trendsin hematopoietic stem cell transplantation in Europe. Blood 2002;100:2374— 86.
   Google Scholar
• Ketterer N, Salles G, Raba M et al. High CD34(±) cell counts decrease hematologic toxicity of autologous peri-pheral blood progenitor cell transplantation. Blood 1998;91:3148— 55.
   Google Scholar
• Medinger P, Tissot JD, Nicoloso de Faveri G et al. Autologoustransplantation of peripheral blood hematopoietic stem cells in the treatment of hematological malignancies. I Patients. Schweiz Med Wochenschr 2000;130:478— 84.
   Google Scholar
• Rowley SD. Current good manufacturing practices: application to the processing of hematopoietic cell components. Cytotherapy 2000;2:59— 62.
   Google Scholar
• Rowley SD. Regulation of hematopoietic stem cell processing and transplantation. Int 7 Hematol 2002;75:237— 45.
   Google Scholar